{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:57Z","timestamp":1792783137103,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:00:00Z","timestamp":1495497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Baxalta US Inc., now part of Shire"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10875-017-0404-8","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T03:12:00Z","timestamp":1495509120000},"page":"461-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Health-Related Quality of Life in Adult Patients with Common Variable Immunodeficiency Disorders and Impact of Treatment"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-0678","authenticated-orcid":false,"given":"Nicholas L.","family":"Rider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carleigh","family":"Kutac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joud","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Scalchunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filiz O.","family":"Seeborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,23]]},"reference":[{"issue":"5","key":"404_CR1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","volume":"27","author":"JM Boyle","year":"2007","unstructured":"Boyle JM, Buckley RH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol. 2007;27(5):497\u2013502.","journal-title":"J Clin Immunol"},{"key":"404_CR2","unstructured":"Immune Deficiency Foundation. Treatment experiences and preferences among patients with primary immunodeficiency diseases: 2007. National Survey of Patients. May 1, 2009a. http:\/\/primaryimmune.org\/idf-survey-research-center\/idf-surveys?aid=1264&sa=1 . Accessed 28 Jul 2016."},{"issue":"2","key":"404_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.aller.2010.10.007","volume":"39","author":"LE Leiva","year":"2011","unstructured":"Leiva LE, Bezrodnik L, Oleastro M, Condino-Neto A, Costa-Carvalho BT, Grumach AS, et al. Primary immunodeficiency diseases in Latin America: proceedings of the Second Latin American Society for Immunodeficiencies (LASID) Advisory Board. Allergol Immunopathol. 2011;39(2):106\u201310.","journal-title":"Allergol Immunopathol"},{"issue":"8","key":"404_CR4","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","volume":"34","author":"L Kobrynski","year":"2014","unstructured":"Kobrynski L, Powell RW, Bowen S. Prevalence and morbidity of primary immunodeficiency diseases, United States 2001\u20132007. J Clin Immunol. 2014;34(8):954\u201361.","journal-title":"J Clin Immunol"},{"issue":"10","key":"404_CR5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/95.10.655","volume":"95","author":"KM Thickett","year":"2002","unstructured":"Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM. 2002;95(10):655\u201362.","journal-title":"QJM"},{"key":"404_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","volume":"116","author":"C Cunningham-Rundles","year":"2010","unstructured":"Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010;116:7\u201315.","journal-title":"Blood"},{"issue":"1","key":"404_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","volume":"33","author":"AA Bousfiha","year":"2013","unstructured":"Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, Abel L. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2013;33(1):1\u20137.","journal-title":"J Clin Immunol"},{"issue":"6","key":"404_CR8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s10875-015-0185-x","volume":"35","author":"H Hernandez-Trujillo","year":"2015","unstructured":"Hernandez-Trujillo H, Orange JS, Roy JA, Wang Y, Newcomb CN, Liu Q, et al. Validity of primary immunodeficiency disease diagnoses in United States Medicaid data. J Clin Immunol. 2015;35(6):566\u201372.","journal-title":"J Clin Immunol"},{"issue":"3","key":"404_CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.semperi.2015.03.004","volume":"39","author":"A Kwan","year":"2015","unstructured":"Kwan A, Puck JM. History and current status of newborn screening for severe combined immunodeficiency. Semin Perinatol. 2015;39(3):194\u2013205.","journal-title":"Semin Perinatol"},{"issue":"1","key":"404_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06212.x","volume":"1238","author":"ME Conley","year":"2011","unstructured":"Conley ME, Notarangelo LD, Casanova JL. Definition of primary immunodeficiency in 2011: a \u201ctrialogue\u201d among friends. Ann N Y Acad Sci. 2011;1238(1):1\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"404_CR11","first-page":"314","volume":"1","author":"MD Cooper","year":"2003","unstructured":"Cooper MD, Lanier LL, Conley ME, Puck JM. Immunodeficiency disorders. ASH Educ Program Book. 2003;1:314\u201330.","journal-title":"ASH Educ Program Book"},{"issue":"6","key":"404_CR12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2014.04.007","volume":"112","author":"HD Ochs","year":"2014","unstructured":"Ochs HD, Hagin D. Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment. Ann Allergy Asthma Immunol. 2014;112(6):489\u201395.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"404_CR13","first-page":"773","volume":"87","author":"CE Reust","year":"2013","unstructured":"Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013;87(11):773\u20138.","journal-title":"Am Fam Physician"},{"key":"404_CR14","unstructured":"Immune Deficiency Foundation. Primary immune deficiency diseases in America: 2002. The Second National Survey of Patients. April 28, 2003a. http:\/\/primaryimmune.org\/idf-survey-research-center\/idf-surveys\/patient-surveys\/?aid=1260&sa=1 . Accessed 28 Jul 2016."},{"key":"404_CR15","unstructured":"Immune Deficiency Foundation. Primary immune deficiency diseases in America: 2008. The Third National Survey of Patients. May 6, 2009b. http:\/\/primaryimmune.org\/idf-survey-research-center\/idf-surveys\/?aid=1268&sa=1 . Accessed 28 Jul 2016."},{"issue":"6","key":"404_CR16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","volume":"3","author":"PJ Maglione","year":"2015","unstructured":"Maglione PJ, Overbey JR, Cunningham-Rundles C. Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings. J Allergy Clin Immunol Pract. 2015;3(6):941\u201350.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"404_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13223-015-0092-y","volume":"11","author":"F Jiang","year":"2015","unstructured":"Jiang F, Torgerson TR, Ayars AG. Health-related quality of life in patients with primary immunodeficiency disease. Allergy Asthma Clin Immunol. 2015;11:27.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"404_CR18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)61469-X","volume":"93","author":"H Tcheurekdjian","year":"2004","unstructured":"Tcheurekdjian H, Palermo T, Hostoffer R. Quality of life in common variable immunodeficiency requiring intravenous immunoglobulin therapy. Ann Allergy Asthma Immunol. 2004;93:160\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"404_CR19","doi-asserted-by":"crossref","unstructured":"Routes J, Costa-Carvalho BT, Grimbacher B, Paris K, Ochs HD, Filipovich A, et al. Health-related quality of life and health resource utilization in patients with primary immunodeficiency disease prior to and following 12 months of immunoglobulin G greatment. J Clin Immunol. 2016;1\u201312.","DOI":"10.1007\/s10875-016-0279-0"},{"key":"404_CR20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fped.2014.00077","volume":"2","author":"M Jesenak","year":"2014","unstructured":"Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr. 2014;2:77.","journal-title":"Front Pediatr"},{"key":"404_CR21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/MCP.0b013e3283642c47","volume":"19","author":"A Prasse","year":"2013","unstructured":"Prasse A, Kayser G, Warnatz K. Common variable immunodeficiency-associated granulomatous and interstitial lung disease. Curr Opin Pulm Med. 2013;19:503\u20139.","journal-title":"Curr Opin Pulm Med"},{"issue":"7","key":"404_CR22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10875-015-0196-7","volume":"35","author":"FO Seeborg","year":"2015","unstructured":"Seeborg FO, Seay R, Boyle M, Boyle J, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015;35(7):638\u201350.","journal-title":"J Clin Immunol"},{"issue":"3","key":"404_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3349\/ymj.2012.53.3.603","volume":"53","author":"I Quinti","year":"2012","unstructured":"Quinti I, Di Pietro C, Martini H, Pesce AM, Lombardi F, Baumghartner M, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J. 2012;53(3):603\u201310.","journal-title":"Yonsei Med J"},{"issue":"4","key":"404_CR24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.iac.2008.07.002","volume":"28","author":"M Berger","year":"2008","unstructured":"Berger M. Subcutaneous administration of IgG. Immunol Allergy Clin N Am. 2008;28(4):779\u2013802.","journal-title":"Immunol Allergy Clin N Am"},{"key":"404_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/cei.12492","volume":"178","author":"VR Bonagura","year":"2014","unstructured":"Bonagura VR. Dose and outcomes in primary immunodeficiency disorders. Clin Exp Immunol. 2014;178:7\u20139.","journal-title":"Clin Exp Immunol"},{"key":"404_CR26","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s10875-010-9423-4","volume":"30","author":"JB Hagan","year":"2010","unstructured":"Hagan JB, Fasano MB, Spector S, Wasserman RL, Melamed I, Rojavin MA, et al. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency. J Clin Immunol. 2010;30:734\u201345.","journal-title":"J Clin Immunol"},{"issue":"12","key":"404_CR27","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s40265-013-0094-3","volume":"73","author":"J Lingman-Framme","year":"2013","unstructured":"Lingman-Framme J, Fasth A. Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review. Drugs. 2013;73(12):1307\u201319.","journal-title":"Drugs"},{"issue":"S1","key":"404_CR28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/cei.12517","volume":"178","author":"SA Misbah","year":"2014","unstructured":"Misbah SA. Effective dosing strategies for therapeutic immunoglobulin: managing wear-off effects in antibody replacement to immunomodulation. Clin Exper Immunol. 2014;178(S1):70\u20131.","journal-title":"Clin Exper Immunol."},{"key":"404_CR29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.2008.03620.x","volume":"152","author":"R Gustafson","year":"2008","unstructured":"Gustafson R, Gardulf A, Hansen S, Leibl H, Engl W, Lind\u00e9n M, et al. Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies. Clin Exper Immunol. 2008;152:274\u20139.","journal-title":"Clin Exper Immunol"},{"key":"404_CR30","unstructured":"Immune Deficiency Foundation. Treatment experiences and preferences among patients with primary immunodeficiency diseases: 2002. National Survey of Patients. June 20, 2003b. http:\/\/primaryimmune.org\/idf-survey-research-center\/idf-surveys\/?aid=1266&sa=1 . Accessed 28 Jul 2016."},{"issue":"S11","key":"404_CR31","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1002\/acr.20541","volume":"63","author":"L Busija","year":"2011","unstructured":"Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-item (SF-36) and Short Form 12-item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQOL). Arthritis Care Res. 2011;63(S11):S383\u2013412.","journal-title":"Arthritis Care Res"},{"key":"404_CR32","volume-title":"SF-12: how to score the SF-12 physical and mental health summary scales","author":"JE Ware","year":"1998","unstructured":"Ware JE, Kosinski M, Keller SD. SF-12: how to score the SF-12 physical and mental health summary scales. 3rd ed. Lincoln: QualityMetric Incorporated; 1998.","edition":"3"},{"issue":"1","key":"404_CR33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaci.2013.12.1077","volume":"134","author":"B Gathmann","year":"2014","unstructured":"Gathmann B, Mahlaoui N, CEREDIH, G\u00e9rard L, Oksenhendler E, Warnatz K, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(1):116\u201326.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"404_CR34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.amjms.2015.12.010","volume":"351","author":"J Dong","year":"2016","unstructured":"Dong J, Liang H, Wen D, Wang J. Common variable immunodeficiency. Am J Med Sci. 2016;351(3):239\u201343.","journal-title":"Am J Med Sci"},{"issue":"3","key":"404_CR35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3349\/ymj.2012.53.3.603","volume":"53","author":"I Quinti","year":"2012","unstructured":"Quinti I, Di Pietro C, Martini H, Pesce AM, Lombardi F, et al. Health related quality of life in common variable immunodeficiency. Yonsei Med J. 2012;53(3):603\u201310.","journal-title":"Yonsei Med J"},{"issue":"1","key":"404_CR36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1759-8893.2011.00076.x","volume":"3","author":"CA Jones","year":"2012","unstructured":"Jones CA, Rojavin M, Baggish JS. Patients with primary immunodeficiency receiving subcutaneous immune globulin Hizentra maintain health-related quality of life and treatment satisfaction in a multicentre extension study of efficacy, tolerability and safety. J Pharm Health Servres. 2012;3(1):41\u20137.","journal-title":"J Pharm Health Servres"},{"issue":"3","key":"404_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.24095\/hpcdp.29.3.03","volume":"29","author":"WM Hopman","year":"2009","unstructured":"Hopman WM, Harrison MB, Coo H, Friedberg E, Buchanan M, VanDenKerkhof EG. Associations between chronic disease, age and physical and mental health status. Chronic Dis Can. 2009;29(3):108\u201316.","journal-title":"Chronic Dis Can"},{"key":"404_CR38","doi-asserted-by":"publisher","unstructured":"Tabolli S, Giannantoni P, Pulvirenti F, La Marra F, Granata G, Milito C, Quinti I. Longitutidinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies. Front Immunol. 2014; doi: 10.3389\/fimmu.2014.00605 .","DOI":"10.3389\/fimmu.2014.00605"},{"issue":"7","key":"404_CR39","first-page":"445","volume":"18","author":"S Ventegodt","year":"2008","unstructured":"Ventegodt S, Flensborg-Madsen T, Andersen NJ, Merrick J. Which factors determine our quality of life, health and ability? Results from a Danish population sample and the Copenhagen Perinatal Cohort. J Coll Physicians Surg Pak. 2008;18(7):445\u201350.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"2","key":"404_CR40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10875-012-9853-2","volume":"33","author":"RS Shapiro","year":"2013","unstructured":"Shapiro RS. Why I use subcutaneous immunoglobulin (SCIG). J Clin Immunol. 2013;33(2):95\u20138.","journal-title":"J Clin Immunol"},{"issue":"2","key":"404_CR41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/oxfordjournals.pubmed.a024606","volume":"19","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson C, Layte R, Jenkinson D, Lawrence K, Petersen S, Paice C, Stradling J. A shorter form health survey: can the SF-12 replicate results from the SF-36 in longitudinal studies. J Public Health Med. 1997;19(2):179\u201386.","journal-title":"J Public Health Med"},{"issue":"8","key":"404_CR42","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jval.2014.09.005","volume":"17","author":"BM Craig","year":"2014","unstructured":"Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, et al. US valuation of health outcomes measured using the PROMIS-29. Value Health. 2014;17(8):846\u201353.","journal-title":"Value Health"},{"issue":"10","key":"404_CR43","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.apmr.2011.04.025","volume":"92","author":"D Amtmann","year":"2011","unstructured":"Amtmann D, Cook KF, Johnson KL, Cella D. The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research. Arch Phys Med Rehabil. 2011;92(10):S12\u20139.","journal-title":"Arch Phys Med Rehabil"},{"issue":"1","key":"404_CR44","first-page":"47","volume":"10","author":"A Aghamohammadi","year":"2011","unstructured":"Aghamohammadi A, Montazeri A, Abolhassani H, Saroukhani S, Pourjabbar S, Tavassoli M, et al. Health-related quality of life in primary antibody deficiency. Iran J Allergy Asthma Immunol. 2011;10(1):47\u201351.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"404_CR45","first-page":"621","volume":"8","author":"J Prevot","year":"2014","unstructured":"Prevot J, Drabwell J. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence. 2014;8:621\u20139.","journal-title":"Patient Prefer Adherence"},{"issue":"Suppl2","key":"404_CR46","first-page":"720","volume":"137","author":"M Ballow","year":"2016","unstructured":"Ballow M, Conaway MR, Rachid RA, Seeborg FO, Sriaroon P, Duff CM, et al. Construction and validation of a health-related quality of life (HR-QOL) instrument for patients with primary antibody deficiency disease. J Allergy Clin Immunol. 2016;137(Suppl2):720. (abstract)","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"404_CR47","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2215\/CJN.07231009","volume":"5","author":"E Lacson","year":"2010","unstructured":"Lacson E, Xu J, Lin SF, Dean SG, Lazarus JM, Hakim RM. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Clin J Am Soc Nephrol. 2010;5(2):252\u201360.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"404_CR48","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11136-010-9691-8","volume":"19","author":"OC Okonkwo","year":"2010","unstructured":"Okonkwo OC, Roth DL, Pulley L, Howard G. Confirmatory factor analysis of the validity of the SF-12 for persons with and without a history of stroke. Qual Life Res. 2010;19(9):1323\u201331.","journal-title":"Qual Life Res"},{"key":"404_CR49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-7525-9-15","volume":"9","author":"S Chariyalertsak","year":"2011","unstructured":"Chariyalertsak S, Wansom T, Kawichai S, Ruangyuttikarna C, Kemerer VF, Wu AW. Reliability and validity of Thai versions of the MOS-HIV and SF-12 quality of life questionnaires in people living with HIV\/AIDS. Health Qual Life Outcomes. 2011;9:15.","journal-title":"Health Qual Life Outcomes"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-017-0404-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-017-0404-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T16:18:31Z","timestamp":1659025111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-017-0404-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,23]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["404"],"URL":"https:\/\/doi.org\/10.1007\/s10875-017-0404-8","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,23]]}}}